By Jill Zorn
The Yale Global Health Justice Partnership (GHJP), in collaboration with the National Physicians Alliance and Universal Health Care Foundation of Connecticut, has released a policy paper entitled, “Curbing Unfair Drug Prices: A Primer for States.”
The high cost of prescription drugs in the United States is unsustainable. Spending on prescription drugs is growing faster than other health care expenses. A growing number of Americans report they are struggling to afford their medications.
While comprehensive federal legislation, the Improving Access to Affordable Prescription Drugs Act, was introduced in the Senate in March, there is little chance that Congress will make significant progress any time soon. That is why state action is so crucial.
States can play a key role in protecting everyday people from unfair and unaffordable prescription drug prices.
Connecticut is one state that has stepped up. We passed an important piece of prescription drug legislation with bi-partisan support, SB 445. And Connecticut’s Health Care Cabinet is focusing its work this year on the issue of high drug costs, both through its regular meetings and through four newly established work groups.
The new report analyzes promising state-level approaches to addressing high and skyrocketing prescription drug prices, providing recommendations to guide policymakers and advocates. It offers a valuable roadmap for Connecticut and other states that are ready to take on the challenge of unaffordable prescription drugs.
To read the report, go here.
To learn more about the work of Connecticut’s Health Care Cabinet on prescription drugs, go here
To follow the work of the Cabinet’s four work groups, go here and scroll down to the work group section.